Invitation to presentation of Xbrane Biopharma’s interim report January – June 2022 on July 22, 2022
Xbrane Biopharma AB invites to a teleconference for investors, analysts and media on Friday, July 22th, 2022, at 10.00 a.m. CET. Xbrane will publish the company’s interim report January – June 2022, on Friday, July 22, 2022, at 8.00 a.m. CET.
Martin Åmark, CEO, and Anette Lindqvist, CFO/IR, will present the interim report January – June 2022, followed by a Q&A session. The presentation will be in English. To attend, please follow the link below: